Statements (61)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Laboratoires_Pierre_Fabre
Alpharma |
| gptkbp:awards |
Various industry awards
|
| gptkbp:clinicalTrials |
Ongoing
|
| gptkbp:collaborations |
Academic institutions
|
| gptkbp:communityEngagement |
Health initiatives
|
| gptkbp:employees |
Over 10,000
|
| gptkbp:established |
1962
|
| gptkbp:exportedTo |
Products to over 130 countries
|
| gptkbp:focus |
Research_and_Development
|
| gptkbp:focusArea |
Cancer treatment
Cardiovascular health Gastroenterology Health education Pain management Urology Women's health Neurology Ophthalmology Pediatrics Personalized medicine Patient-centered care Telemedicine Vaccines Geriatrics Clinical guidelines Chronic disease management Biologics Global health initiatives Access to medicines Health technology assessment Skin health Men's health Preventive health Biosimilars Health policy advocacy Respiratory health Allergy treatment Digital_health_solutions Orphan_drugs |
| gptkbp:foundedBy |
gptkb:Pierre_Fabre
|
| gptkbp:headquarters |
gptkb:Castres,_France
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pierre Fabre Santé
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:innovation |
New drug development
|
| gptkbp:is_committed_to |
Environmental sustainability
|
| gptkbp:leadership |
gptkb:Pierre_Fabre_Group
|
| gptkbp:market |
Global
|
| gptkbp:partnerships |
Various healthcare organizations
|
| gptkbp:patentCitation |
Numerous in pharmaceuticals
|
| gptkbp:philosophy |
Sustainable development
|
| gptkbp:products |
Oncology
Dermatology Consumer Health |
| gptkbp:research_areas |
Multiple_locations_in_France
|
| gptkbp:revenue |
€2.3 billion (2020)
|
| gptkbp:socialResponsibility |
Commitment to health and well-being
|
| gptkbp:subsidiary |
gptkb:Pierre_Fabre_Médicament
gptkb:Pierre_Fabre_Dermo-Cosmétique |
| gptkbp:website |
www.pierre-fabre.com
|